Surgical Treatments for Obstructive Sleep Apnea
Cigna Medical Coverage Policy 0158 defines medical necessity, not medically necessary, and experimental/investigational positions for specific surgical procedures and implanted devices used to treat obstructive sleep apnea (OSA), plus DISE diagnostic use and coding guidance. This part covers coverage policy statements, selected required criteria for procedures/devices, and coding lists.
Revised policy statement for implantable upper airway hypoglossal nerve stimulation device in adults (BMI).
Revised policy statement for implantable upper airway hypoglossal nerve stimulation device in pediatric individual with Down syndrome (BMI).
Revised policy statement for drug-induced sleep endoscopy (DISE) in adults.
Revised policy statement for uvulectomy.
Removed policy statement for tongue implant (e.g., ReVENT® Sleep Apnea System).
Removed statements and codes addressing tracheostomy, tonsillectomy and adenoidectomy.
Removed statements pertaining to replacement of generator battery and/or leads and LAUP.
Updated coverage statement addressing use of hypoglossal airway stimulation in adults based on current FDA language.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.